Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery
· Nature Biotechnology publication details improved calibration framework for deep learning-based [...]
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
Four sessions across two days focusing on key drug discovery [...]
Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine
Laverock's programmable gene control platform unlocks in vivo therapeutics with [...]
Cytotrait appoints Dr Ian Jepson as Non-Executive Director
Accomplished international R&D executive, previously Syngenta, specialising in biotech trait [...]
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
First new floor-standing centrifuge developed since the integration of himac [...]
Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy
Study published in ‘Expert Review of Ophthalmology’ demonstrates potential to [...]
Nuclera appoints Carl Raimond as Chief Executive Officer
Former Olink Proteomics President brings extensive life-science tools leadership experience, [...]
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M [...]
Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform
Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, [...]
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 [...]